Company / Interest Expense per Share
Vaxcyte, Inc. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-
FY2023
5-year range
$0.00 / $0.00
FY2019-FY2023
Trend
-100.0%
vs FY2022
Sector context
#39 of 43
Health Care
What the data says
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 43
▼
Key checks
Key Insights
- Vaxcyte, Inc.'s interest expense per share has declined for 5 consecutive years.
- In FY2023, interest expense per share decreased 100.0% year-over-year.
- Peak interest expense per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.00 | -77.1% |
| FY2021 | $0.00 | -43.1% |
| FY2020 | $0.00 | -97.8% |
| FY2019 | $0.01 | -49.0% |
| FY2018 | $0.02 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026